BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 16609910)

  • 1. Cytokeratin 7/20 and mucin core protein expression in ulcerative colitis-associated colorectal neoplasms.
    Tatsumi N; Kushima R; Vieth M; Mukaisho K; Kakinoki R; Okabe H; Borchard F; Stolte M; Okanoue T; Hattori T
    Virchows Arch; 2006 Jun; 448(6):756-62. PubMed ID: 16609910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of ATF6 as a marker of pre-cancerous atypical change in ulcerative colitis-associated colorectal cancer: a potential role in the management of dysplasia.
    Hanaoka M; Ishikawa T; Ishiguro M; Tokura M; Yamauchi S; Kikuchi A; Uetake H; Yasuno M; Kawano T
    J Gastroenterol; 2018 May; 53(5):631-641. PubMed ID: 28884228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Midkine expression in colorectal tumors: correlation with Ki-67 labeling in sporadic, but not ulcerative colitis-associated ones.
    Tokuyama W; Mikami T; Fujiwara M; Matsui T; Okayasu I
    Pathol Int; 2007 May; 57(5):260-7. PubMed ID: 17493173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metallothionein: early marker in the carcinogenesis of ulcerative colitis-associated colorectal carcinoma.
    Bruewer M; Schmid KW; Krieglstein CF; Senninger N; Schuermann G
    World J Surg; 2002 Jun; 26(6):726-31. PubMed ID: 12053227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of mucin glycoproteins and cytokeratins in intrahepatic cholangiocarcinoma].
    Zhao SM; Zhu XZ; Ji Y; Hou J
    Zhonghua Bing Li Xue Za Zhi; 2008 Nov; 37(11):749-53. PubMed ID: 19094709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 immunohistochemistry of ulcerative colitis-associated with dysplasia and carcinoma.
    Sato A; MacHinami R
    Pathol Int; 1999 Oct; 49(10):858-68. PubMed ID: 10571818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of cytokeratins 7 and 20 in serrated adenoma and related diseases.
    Tatsumi N; Mukaisho K; Mitsufuji S; Tatsumi Y; Sugihara H; Okanoue T; Hattori T
    Dig Dis Sci; 2005 Sep; 50(9):1741-6. PubMed ID: 16133982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic alterations of mucins and cytokeratins during gallbladder carcinogenesis.
    Chang HJ; Kim SW; Lee BL; Hong EK; Kim WH
    Pathol Int; 2004 Aug; 54(8):576-84. PubMed ID: 15260848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoreactivity of cytokeratins (CK7, CK20) and mucin peptide core antigens (MUC1, MUC2, MUC5AC) in adenocarcinomas, normal and metaplastic tissues of the distal oesophagus, oesophago-gastric junction and proximal stomach.
    Flucke U; Steinborn E; Dries V; Mönig SP; Schneider PM; Thiele J; Hölscher AH; Dienes HP; Baldus SE
    Histopathology; 2003 Aug; 43(2):127-34. PubMed ID: 12877727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clear cell change in colonic tubular adenoma and corresponding colonic clear cell adenocarcinoma is associated with an altered mucin core protein profile.
    Shi C; Scudiere JR; Cornish TC; Lam-Himlin D; Park JY; Fox MR; Montgomery EA
    Am J Surg Pathol; 2010 Sep; 34(9):1344-50. PubMed ID: 20697252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokeratin expression profiling in gastric carcinoma: clinicopathologic significance and comparison with tumor-associated molecules.
    Takami H; Sentani K; Matsuda M; Oue N; Sakamoto N; Yasui W
    Pathobiology; 2012; 79(3):154-61. PubMed ID: 22286119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histomorphologic and molecular features of pouch and peripouch adenocarcinoma: a comparison with ulcerative colitis-associated adenocarcinoma.
    Jiang W; Shadrach B; Carver P; Goldblum JR; Shen B; Liu X
    Am J Surg Pathol; 2012 Sep; 36(9):1385-94. PubMed ID: 22895272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular profiling of ulcerative colitis-associated neoplastic progression.
    Colliver DW; Crawford NP; Eichenberger MR; Zacharius W; Petras RE; Stromberg AJ; Galandiuk S
    Exp Mol Pathol; 2006 Feb; 80(1):1-10. PubMed ID: 16277983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucin core polypeptide expression in the progression of neoplasia in Barrett's esophagus.
    Glickman JN; Blount PL; Sanchez CA; Cowan DS; Wongsurawat VJ; Reid BJ; Odze RD
    Hum Pathol; 2006 Oct; 37(10):1304-15. PubMed ID: 16949933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of mucin core proteins, trefoil factors, APC and p21 in subsets of colorectal polyps and cancers suggests a distinct pathway of pathogenesis of mucinous carcinoma of the colorectum.
    Kim DH; Kim JW; Cho JH; Baek SH; Kakar S; Kim GE; Sleisenger MH; Kim YS
    Int J Oncol; 2005 Oct; 27(4):957-64. PubMed ID: 16142311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary.
    Park SY; Kim HS; Hong EK; Kim WH
    Hum Pathol; 2002 Nov; 33(11):1078-85. PubMed ID: 12454811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive correlation of expression of L-type amino-acid transporter 1 with colorectal tumor progression and prognosis: Higher expression in sporadic colorectal tumors compared with ulcerative colitis-associated neoplasia.
    Sakata T; Hana K; Mikami T; Yoshida T; Endou H; Okayasu I
    Pathol Res Pract; 2020 Jun; 216(6):152972. PubMed ID: 32359697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered expression of CK7 and CK20 in preneoplastic and neoplastic lesions in ulcerative colitis.
    Stenling R; Lindberg J; Rutegård J; Palmqvist R
    APMIS; 2007 Nov; 115(11):1219-26. PubMed ID: 18092953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotensin receptor 1 overexpression in inflammatory bowel diseases and colitis-associated neoplasia.
    Gui X; Liu S; Yan Y; Gao Z
    World J Gastroenterol; 2013 Jul; 19(28):4504-10. PubMed ID: 23901225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical distinction of intestinal-type sinonasal adenocarcinoma from metastatic adenocarcinoma of intestinal origin.
    Resto VA; Krane JF; Faquin WC; Lin DT
    Ann Otol Rhinol Laryngol; 2006 Jan; 115(1):59-64. PubMed ID: 16466101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.